DNASE1L3-mediated PANoptosis enhances the efficacy of combination therapy for advanced hepatocellular carcinoma
Theranostics · 2024 · 14 (17) · 6798-6817
DOI: 10.7150/thno.102995 ↗Kurz gefasst
Fachartikel in der Zeitschrift Theranostics, 2024. Verfasst von Jingchun Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Second Affiliated Hospital, Army Medical University; Chongqing 400037, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Sorafenib, Endodeoxyribonucleases. Die Arbeit wurde bisher 31-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Second Affiliated Hospital, Army Medical University; Chongqing 400037, China.
- Department of Medical Oncology, Chongqing University Cancer Hospital; Chongqing 400030, China.
- Clinical Medicine Research Center, Second Affiliated Hospital, Army Medical University; Chongqing 400037, China.
- Department of Pathology, First Affiliated Hospital, Army Medical University; Chongqing 400037, China.
Zitieren
APA
Wang, J., Chen, Y., Xu, Y., Zhang, J., Yang, S., Zhou, Y., Lei, J., Ren, R., Chen, Y., Zhao, H., Li, Y., & Yang, S. (2024). DNASE1L3-mediated PANoptosis enhances the efficacy of combination therapy for advanced hepatocellular carcinoma. Theranostics, 14(17), 6798-6817. https://doi.org/10.7150/thno.102995
Vancouver
Wang J, Chen Y, Xu Y, Zhang J, Yang S, Zhou Y, et al. DNASE1L3-mediated PANoptosis enhances the efficacy of combination therapy for advanced hepatocellular carcinoma. Theranostics. 2024;14(17):6798-6817. doi:10.7150/thno.102995
BibTeX
@article{Wang2024,
author = {Wang, Jingchun and Chen, Yu and Xu, Yanquan and Zhang, Jiangang and Yang, Shuai and Zhou, Yu and Lei, Juan and Ren, Ran and Chen, Yang and Zhao, Huakan and Li, Yongsheng and Yang, Shiming},
title = {DNASE1L3-mediated PANoptosis enhances the efficacy of combination therapy for advanced hepatocellular carcinoma},
journal = {Theranostics},
year = {2024},
volume = {14},
number = {17},
pages = {6798--6817},
doi = {10.7150/thno.102995}
}
EUVIMED